Luca De Rosa

Combination chemotherapy versus melphalan plus prednisone as treatment for multiple myeloma: An overview of 6,633 patients from 27 randomized trials

Stefano Pasquali, J D Maqueo, Jorge Espino Vela et al. · Oxford University Research Archive (ORA) (University of Oxford) · 1998 · 473 citations

Hematological Malignancy, Oncology, Metronomic Therapy +6

Efficacy and safety of once-weekly bortezomib in multiple myeloma patients

Alessandra Larocca, Davide Rossi, Maide Cavalli et al. · Blood · 2010 · 379 citations · Full text

Major Tumor Shrinking and Persistent Molecular Remissions After Consolidation With Bortezomib, Thalidomide, and Dexamethasone in Patients With Autografted Myeloma

Marco Ladetto, G Pagliano, Simone Ferrero et al. · Journal of Clinical Oncology · 2010 · 267 citations · Full text

Cell Therapy, Autografted Myeloma, Immunology +19

Oral ixazomib maintenance following autologous stem cell transplantation (TOURMALINE-MM3): a double-blind, randomised, placebo-controlled phase 3 trial

Meletios Α. Dimopoulos, Francesca Gay, Fredrik Schjesvold et al. · The Lancet · 2018 · 231 citations · Full text

Regenerative Medicine, Cell Therapy, Transplantation +7

Long-term results of the GIMEMA VEL-03-096 trial in MM patients receiving VTD consolidation after ASCT: MRD kinetics' impact on survival

Simone Ferrero, Marco Ladetto, Daniela Drandi et al. · Leukemia · 2014 · 83 citations

Oncology, Mm Patients, Vtd Consolidation +5